References
- Antunes C MF, Stolly P D., Rosenheim N B., et al. Endometrial cancer and estrogen use. N Engl J Med 1979; 300: 9
- Berger G S., Fowler W C. Exogenous estrogens and endometrial carcinoma: Review and comments for the clinician. J Reprod Med 1977; 18: 177
- Dennerstein L, Burrows C D., Hyman G, Wood C. Menopausal hot flushes: A double-blind comparison of placebo, ethinyl oestradiol and norgestrel. Br J Obstet Gynaecol 1978; 85: 852
- Gambrell R D., Castaneda T A., Ricci C A. Management of postmenopausal bleeding to prevent endometrial cancer. Maturitas 1978; 1: 99
- Gusberg S B., Kaplan A L. Precursors of corpus cancer. IV. Adenomatous hyperplasia as stage 0 carcinoma. Am J Obstet Gynecol 1963; 87: 662
- King R JB, Whitehead M I., Cambell S, Minardi J. Biochemical studies on the endometrium from postmenopausal women receiving hormone replacement therapy. Postgrad Med J 1978; 54: 65
- Lauritzen C. Oestrogens and endometrial cancer: A point of view. Clin Obstet Gynecol 1977; 4: 145
- Mack T M., Pike M C., Henderson B E., et al. Estrogens and endometrial cancer in a retirement community. N Engl J Med 1976; 294: 1262
- Mattsson L-Å, Cullberg G, Samsioe G. Evaluation of a continuous oestrogen-progestogen regimen for climacteric complaints. Maturitas 1982; 4: 95
- Mattsson L-Å, Cullberg G, Samsioe G. The influence of continuous oestrogen-progestogen therapy for climacteric complaints on lipid and lipoprotein metabolism. Acta Obstet Gynecol Scand 1984; 63: 673
- Persson J. Climacteric treatment with estrogens and estrogen-progestogen combinations: The risk of endometrial neoplasia. Acta Universitatis Upsaliensis (Diss.) 1979; 471
- Rust J E., Langley I I., Hill E C., Lamb E J. Estrogens: Do the risks outweigh the benefits?. Am J Obstet Gynecol 1977; 128: 431
- Salmi T. Risk factors in endometrial carcinoma with special reference to the use of estrogens. Acta Obstet Gynecol Scand (Suppl) 1979; 86
- Smith D C., Prentice R, Thompson D, Herrman W. Association of exogenous estrogens and endometrial carcinoma. N Engl J Med 1975; 293: 1164
- Staland B. Continuous treatment with natural oestrogens and progestogens. A method to avoid endometrial stimulation. Maturitas 1981; 3: 145
- Staland B. Absorption of an oestrogen-progestogen preparation. Maturitas 1983; 5: 85
- Tseng L, Gurpide E. Effect of estrone and progesterone on the nuclear uptake of estradiol by slices of human endometrium. Endocrinology 1973; 93: 245
- Weiss N S. Risk and benefit of estrogen use. N Engl J Med 1975; 293: 1200
- Yen S SC, Martin P L., Burnier A M., Greaney M O., Jr. Circulating estradiol, estrone and gonadotrophin levels following the administration of orally active 17-β-est-radiol in postmenopausal women. J Clin Endocrinol Metab 1975; 40: 518
- Ziel H, Finkle W. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med 1975; 293: 1167